Pentoxifylline and tocopherol in the management of patients with osteoradionecrosis, the Portsmouth experience
- PMID: 21247671
- DOI: 10.1016/j.bjoms.2010.11.017
Pentoxifylline and tocopherol in the management of patients with osteoradionecrosis, the Portsmouth experience
Abstract
Osteoradionecrosis of the jaw remains the most problematic consequence of radiotherapy for the management of head and neck cancer. Treatment is often complex and multimodal. New theories on its pathophysiology have allowed the development of potential treatment modalities, including the use of pentoxifylline and tocopherol. In this retrospective case series we examined the outcomes of patients with ORN prescribed pentoxifylline and tocopherol.
Copyright © 2010 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
